Colin McCall looks at the current regulation of medical devices.
A legal toolkit for life sciences companies and their investors providing access to information on:
Britta Bröker discusses the EPO's decision to adopt a system of renewal fees for unitary patents that strikes a balance between workability for the UPC and affordability for patentees...read more
Paul England comments on the recent Court of Appeal decision in Warner-Lambert v Actavis regarding direct and indirect infringement of a Swiss-type second medical use claim....read more
Amanda Rowell discusses a number of issues identified by the O'Neill review on antimicrobial resistance and looks at proposed solutions....read more
Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...